Combination of 5-Fluorouracil With Epigenetic Modifiers Induces Radiosensitization, Somatostatin Receptor 2 Expression and Radioligand Binding in Neuroendocrine Tumor Cells in Vitro

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.118.224048
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine

Related search

Neuroendocrine Neoplasms and Somatostatin Receptor Subtypes Expression

Nuclear Medicine Review
MedicineNuclear MedicineRadiologyImaging
2016English

Different Effects of Epigenetic Modifiers on the Cytotoxicity Induced by 5-Fluorouracil, Irinotecan or Oxaliplatin in Colon Cancer Cells

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2014English

Ligand Binding to Somatostatin Receptors Induces Receptor-Specific Oligomer Formation in Live Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2002English

Differential Expression and Tumorigenic Function of Neurotensin Receptor 1 in Neuroendocrine Tumor Cells

Oncotarget
Oncology
2015English

Somatostatin Receptor Type 5 Modulates Somatostatin Receptor Type 2 Regulation of Adrenocorticotropin Secretion

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

Enzymatic Formation of 5-Fluorouracil From 1-(Tetrahydro-2-Furanyl)-5-Fluorouracil (Tegafur) in Human Tumor Tissues.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1981English

Somatostatin Receptor Endoradiotherapy of Neuroendocrine Tumors: Experience in Hungarian Patients

Orvosi Hetilap
Medicine
2011English

The Synergistic in Vitro and in Vivo Antitumor Effect of Combination Therapy With Salinomycin and 5-Fluorouracil Against Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2014English

In Vitro Synergistic Antitumor Activity of a Combination of 5-Fluorouracil and Irinotecan in Human Colon Cancer

International Journal of Oncology
Cancer ResearchOncology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy